ARGX logo

Argenx SE (ARGX) EBITDA

Annual EBITDA

$105.17 M
+$297.46 M+154.70%

December 1, 2024

Summary

Performance

1-Year Change

+154.7%

3-Year Change

+126.78%

5-Year Change

+160.67%

15-Year Change

+424.15%

ARGX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.61%
ARGX annual EBITDA is higher than 87.61% of companies in Healthcare sector

High & Low

All-time High

$105.17 M
ARGX annual EBITDA is currently at an all-time high

3-Year Low

-$622.78 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
ARGX previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
ARGX next annual earnings announcement has not yet been scheduled

OtherARGXprofitabilitymetrics:

Annual Revenue

$2.19 B
ARGX annual revenue is $2.19 billion

Annual Net Income

$833.04 M
ARGX annual net profit is $833.04 million

Annual EBIT

$87.64 M
ARGX annual earnings before interest & taxes is $87.64 million

Annual EPS

$12.78
ARGX annual earnings per share is $12.78

Quarterly EBITDA

$87.21 M
-$1.49 M-1.68%

December 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+704.34%

3-Year Change

+204.25%

5-Year Change

+183.8%

ARGX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.2%
ARGX quarterly EBITDA is higher than 90.2% of companies in Healthcare sector

High & Low

All-time High

$106.44 M
ARGX quarterly EBITDA is currently -18.06% below its historical high of $106.44 million

3-Year Low

-$247.26 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ARGX previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

N/A
ARGX next earnings announcement has not yet been scheduled

OtherARGXprofitabilitymetrics:

Quarterly Revenue

$738.41 M
ARGX quarterly revenue is $738.41 million

Quarterly Net Income

$774.16 M
ARGX quarterly net profit is $774.16 million

Quarterly EBIT

$87.21 M
ARGX quarterly earnings before interest & taxes is $87.21 million

Quarterly EPS

$11.87
ARGX quarterly earnings per share is $11.87

TTM EBITDA

$87.64 M
+$148.11 M+244.94%

December 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+137.74%

3-Year Change

+119.84%

5-Year Change

+149.86%

ARGX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.27%
ARGX TTM EBITDA is higher than 86.27% of companies in Healthcare sector

High & Low

All-time High

$87.64 M
ARGX TTM EBITDA is currently at an all-time high

3-Year Low

-$932.42 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ARGX previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

N/A
ARGX next earnings announcement has not yet been scheduled

OtherARGXprofitabilitymetrics:

TTM Revenue

$2.19 B
ARGX TTM revenue is $2.19 billion

TTM Net Income

$833.04 M
ARGX TTM net profit is $833.04 million

TTM EBIT

$87.64 M
ARGX TTM earnings before interest & taxes is $87.64 million

TTM EPS

$12.71
ARGX TTM earnings per share is $12.71

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$105.17 M
ARGX annual EBITDA is $105.17 million

Annual Net Income

$833.04 M
ARGX annual net profit is $833.04 million

Annual Interest Expense

$2.46 M
ARGX annual interest expense is $2.46 million

Annual Income Tax

-$747.86 M
ARGX annual income tax is -$747.86 million

Annual D&A

$17.53 M
ARGX annual depreciation & amortization is $17.53 million

ARGX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+154.7%+704.3%+137.7%
3 y3 years+126.8%+204.3%+119.8%
5 y5 years+160.7%+183.8%+149.9%

ARGX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+116.9%-1.7%+135.3%at high+109.4%
5 y5-yearat high+116.9%-18.1%+135.3%at high+109.4%
alltimeall timeat high+116.9%-18.1%+135.3%at high+109.4%

Argenx SE EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$105.17 M(-154.7%)
$87.21 M(-1.7%)
$87.64 M(-244.9%)
Sep 2024
-
$88.70 M(-714.6%)
-$60.47 M(-74.0%)
Jun 2024
-
-$14.43 M(-80.5%)
-$232.22 M(-23.0%)
Mar 2024
-
-$73.84 M(+21.2%)
-$301.44 M(-0.7%)
Dec 2023
-$192.28 M(-69.1%)
-$60.90 M(-26.7%)
-$303.59 M(+6.7%)
Sep 2023
-
-$83.05 M(-0.7%)
-$284.65 M(-35.6%)
Jun 2023
-
-$83.65 M(+10.1%)
-$441.85 M(-23.0%)
Mar 2023
-
-$75.99 M(+81.1%)
-$573.99 M(-21.1%)
Dec 2022
-$622.78 M(+58.6%)
-$41.96 M(-82.5%)
-$727.12 M(-22.0%)
Sep 2022
-
-$240.24 M(+11.3%)
-$932.42 M(+1.1%)
Jun 2022
-
-$215.80 M(-5.8%)
-$921.94 M(+53.7%)
Mar 2022
-
-$229.12 M(-7.3%)
-$599.70 M(+50.4%)
Dec 2021
-$392.78 M(-34.6%)
-$247.26 M(+7.6%)
-$398.65 M(+163.3%)
Sep 2021
-
-$229.77 M(-315.9%)
-$151.39 M(-293.2%)
Jun 2021
-
$106.44 M(-479.3%)
$78.38 M(-379.3%)
Mar 2021
-
-$28.07 M(-73.0%)
-$28.07 M(-84.0%)
Dec 2020
-$601.03 M(+246.7%)
-
-
Dec 2019
-$173.35 M(+86.3%)
-$104.07 M(+964.4%)
-$175.78 M(+59.2%)
Sep 2019
-
-$9.78 M(-82.3%)
-$110.40 M(-12.5%)
Jun 2019
-
-$55.14 M(+712.9%)
-$126.20 M(+60.5%)
Mar 2019
-
-$6.78 M(-82.5%)
-$78.64 M(-16.0%)
Dec 2018
-$93.06 M
-$38.69 M(+51.2%)
-$93.63 M(+29.9%)
Sep 2018
-
-$25.58 M(+237.3%)
-$72.07 M(+34.4%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$7.58 M(-65.2%)
-$53.63 M(+17.2%)
Mar 2018
-
-$21.77 M(+27.0%)
-$45.75 M(+38.8%)
Dec 2017
-$32.44 M(+46.3%)
-$17.14 M(+140.1%)
-$32.97 M(+35.9%)
Sep 2017
-
-$7.14 M(-2543.0%)
-$24.25 M(+5.3%)
Jun 2017
-
$292.20 K(-103.3%)
-$23.03 M(-18.2%)
Mar 2017
-
-$8.98 M(+6.7%)
-$28.14 M(+24.9%)
Dec 2016
-$22.17 M(+34.2%)
-$8.42 M(+42.2%)
-$22.52 M(+16.6%)
Sep 2016
-
-$5.92 M(+23.0%)
-$19.32 M(+15.0%)
Jun 2016
-
-$4.82 M(+43.1%)
-$16.79 M(+1.1%)
Mar 2016
-
-$3.37 M(-35.4%)
-$16.61 M(-0.8%)
Dec 2015
-$16.53 M(+33.5%)
-$5.21 M(+53.6%)
-$16.74 M(+6.8%)
Sep 2015
-
-$3.39 M(-26.7%)
-$15.67 M(+8.5%)
Jun 2015
-
-$4.63 M(+32.4%)
-$14.44 M(+7.7%)
Mar 2015
-
-$3.50 M(-15.6%)
-$13.40 M(+7.4%)
Dec 2014
-$12.38 M(+49.2%)
-$4.14 M(+91.7%)
-$12.48 M(+21.1%)
Sep 2014
-
-$2.16 M(-39.9%)
-$10.30 M(+25.0%)
Jun 2014
-
-$3.59 M(+39.3%)
-$8.24 M(-4.3%)
Mar 2014
-
-$2.58 M(+31.2%)
-$8.61 M(+2.6%)
Dec 2013
-$8.29 M(-34.0%)
-$1.97 M(+1860.0%)
-$8.39 M(+30.6%)
Sep 2013
-
-$100.30 K(-97.5%)
-$6.43 M(+1.6%)
Jun 2013
-
-$3.97 M(+68.0%)
-$6.33 M(+168.0%)
Mar 2013
-
-$2.36 M
-$2.36 M
Dec 2012
-$12.56 M(+198.9%)
-
-
Dec 2011
-$4.20 M
-
-

FAQ

  • What is argenx SE annual EBITDA?
  • What is the all time high annual EBITDA for argenx SE?
  • What is argenx SE annual EBITDA year-on-year change?
  • What is argenx SE quarterly EBITDA?
  • What is the all time high quarterly EBITDA for argenx SE?
  • What is argenx SE quarterly EBITDA year-on-year change?
  • What is argenx SE TTM EBITDA?
  • What is the all time high TTM EBITDA for argenx SE?
  • What is argenx SE TTM EBITDA year-on-year change?

What is argenx SE annual EBITDA?

The current annual EBITDA of ARGX is $105.17 M

What is the all time high annual EBITDA for argenx SE?

argenx SE all-time high annual EBITDA is $105.17 M

What is argenx SE annual EBITDA year-on-year change?

Over the past year, ARGX annual EBITDA has changed by +$297.46 M (+154.70%)

What is argenx SE quarterly EBITDA?

The current quarterly EBITDA of ARGX is $87.21 M

What is the all time high quarterly EBITDA for argenx SE?

argenx SE all-time high quarterly EBITDA is $106.44 M

What is argenx SE quarterly EBITDA year-on-year change?

Over the past year, ARGX quarterly EBITDA has changed by +$101.64 M (+704.34%)

What is argenx SE TTM EBITDA?

The current TTM EBITDA of ARGX is $87.64 M

What is the all time high TTM EBITDA for argenx SE?

argenx SE all-time high TTM EBITDA is $87.64 M

What is argenx SE TTM EBITDA year-on-year change?

Over the past year, ARGX TTM EBITDA has changed by +$319.86 M (+137.74%)